IP Library Granted Patent US 12,598,909
Granted Patent B2
US 12,598,909 · App. 16/529,327 · Granted Apr 7, 2026

Heterocyclic compound and organic light-emitting device including the same

Inventors: Heechoon Ahn (Yongin-si, KR); Hyeongmin Kim (Yongin-si, KR); Hyunah Um (Yongin-si, KR); Yeseul Lee (Yongin-si, KR); Yirang Im (Yongin-si, KR); Soobyung Ko (Yongin-si, KR); Youngkook Kim (Yongin-si, KR)
Assignee: Samsung Display Co., Ltd.
H10K85/40C07F7/0812C09K11/06H10K85/636H10K85/654H10K85/6572H10K85/6574C09K2211/1018H10K50/11H10K2101/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,598,909
App. No.
16/529,327
Granted
Apr 7, 2026
Kind
B2
Abstract

A heterocyclic compound is represented by Formula 1. An organic light-emitting device includes: a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode and including an emission layer, wherein the organic light-emitting device includes at least one of the heterocyclic compound.

Claims (124)

1 . An organic light-emitting device comprising:

a first electrode;

a second electrode facing the first electrode;

an organic layer between the first electrode and the second electrode and comprising an emission layer; and

at least one heterocyclic compound represented by Formula 1:

wherein, in Formulae 1, 2-1 and 2-3,

X 1 to X 3 are each independently N or C(R 15 ), wherein at least one selected from X 1 to X 3 is N,

L 1 to L 3 are each independently a substituted or unsubstituted C 3 -C 60 carbocyclic group or a substituted or unsubstituted C 1 -C 60 heterocyclic group,

a1 to a3 are each independently an integer from 0 to 3,

Ar 1 is a group represented by Formula 2-1. Ar 2 is a group represented by Formula 2-3, Ar 3 is a group represented by Formula 2-3,

R 1 is selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 2 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —S(═O) 2 (Q 1 ), and —P(═O)(Q 1 )(Q 2 ),

R 4 and R 5 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, an unsubstituted C 2 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —S(═O) 2 (Q 1 ), and —P(═O)(Q 1 )(Q 2 ),

b4 is an integer from 1 to 4, and b5 is an integer from 1 to 5,

at least one selected from the R 1 of the Formula 2-1 is—Si (Q 1 )(Q 2 )(Q 3 ),

at least one substituent of the substituted C 3 -C 60 carbocyclic group, the substituted C 1 -C 60 heterocyclic group, the substituted C 1 -C 60 alkyl group, the substituted C 2 -C 60 alkenyl group, the substituted C 2 -C 60 alkynyl group, the substituted C 1 -C 60 alkoxy group, the substituted C 3 -C 10 cycloalkyl group, the substituted C 2 -C 10 heterocycloalkyl group, the substituted C 3 -C 10 cycloalkenyl group, the substituted C 2 -C 10 heterocycloalkenyl group, the substituted C 6 -C 60 aryl group, the substituted C 6 -C 60 aryloxy group, the substituted C 6 -C 60 arylthio group, the substituted C 2 -C 60 heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group is selected from:

deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, and a C 1 -C 60 alkoxy group;

a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, and a C 1 -C 60 alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), and —P(═O)(Q 11 )(Q 12 );

a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group;

a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, a terphenyl group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), and —P(═O)(Q 21 )(Q 22 ); and

—Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), and —P(═O)(Q 31 )(Q 32 ),

Q 1 to Q 3 , Q 11 to Q 13 , Q 21 to Q 23 , and Q 31 to Q 33 are each independently selected from:

hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryl group substituted with a C 1 -C 60 alkyl group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group; and

a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryl group substituted with a C 1 -C 60 alkyl group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group, and —Si(R a )(R b )(R c ),

R a to R c are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 2 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group,

* indicates a binding site to a neighboring atom.

2 . The organic light-emitting device of claim 1 , wherein:

the first electrode is an anode,

the second electrode is a cathode,

the organic layer comprises at least one of the heterocyclic compound,

the organic layer further comprises a hole transport region between the first electrode and the emission layer and an electron transport region between the emission layer and the second electrode,

the hole transport region comprises a hole injection layer, a hole transport layer, an emission auxiliary layer, an electron blocking layer, or any combination thereof, and

the electron transport region comprises a hole blocking layer, an electron transport layer, an electron injection layer, or any combination thereof.

3 . The organic light-emitting device of claim 1 , wherein:

the emission layer comprises a dopant and a host, and

the host comprises at least one of the heterocyclic compound.

4 . The organic light-emitting device of claim 3 , wherein:

the dopant is a phosphorescent dopant.

5 . The organic light-emitting device of claim 3 , wherein:

the dopant comprises an organometallic complex represented by Formula 401:

wherein, in Formulae 401 and 402,

M is selected from iridium (Ir), platinum (Pt), palladium (Pd), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), rhodium (Rh), and thulium (Tm),

L 401 is selected from ligands represented by Formula 402, and xc1 is 1, 2, or 3, wherein, when xc1 is two or more, two or more L 401 (s) are identical to or different from each other,

L 402 is an organic ligand, and xc2 is an integer from 0 to 4, wherein, when xc2 is two or more, two or more L 402 (s) are identical to or different from each other,

X 401 to X 404 are each independently nitrogen or carbon,

X 401 and X 403 are linked via a single bond or a double bond, and X 402 and X 404 are linked via a single bond or a double bond,

A 401 and A 402 are each independently a C 5 -C 60 carbocyclic group or a C 1 -C 60 heterocyclic group,

X 405 is a single bond, *—O—*′, *—S—*′, *—C(═O)—*′, *—N(Q 411 )-*′, *—C(Q 411 )(Q 412 )-*′, *—C(Q 411 )=C(Q 412 )-*′, *—C(Q 411 )=*′, or *═C(Q 411 )═*′, wherein Q 411 and Q 412 are each independently hydrogen, deuterium, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, or a naphthyl group,

X 406 is a single bond, O, or S,

R 401 and R 402 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a substituted or unsubstituted C 1 -C 20 alkyl group, a substituted or unsubstituted C 1 -C 20 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 1 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 1 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 401 )(Q 402 )(Q 403 ), —N(Q 401 )(Q 402 ), —B(Q 401 )(Q 402 ), —C(═O)(Q 401 ), —S(═O) 2 (Q 401 ), and —P(═O)(Q 401 )(Q 402 ), wherein Q 401 to Q 403 are each independently selected from a C 1 -C 10 alkyl group, a C 1 -C 10 alkoxy group, a C 6 -C 20 aryl group, and a C 1 -C 20 heteroaryl group,

xc11 and xc12 are each independently an integer from 0 to 10, and

* and *′ in Formula 402 each indicate a binding site to M in Formula 401.

6 . The organic light-emitting device of claim 2 , wherein:

the hole transport region further comprises a p-dopant having a lowest unoccupied molecular orbital (LUMO) energy level of about −3.5 eV or less.

7 . The organic light-emitting device of claim 2 , wherein:

the electron transport region comprises an alkali metal, an alkaline earth metal, a rare earth metal, an alkali metal compound, an alkaline earth metal compound, a rare earth metal compound, an alkali metal complex, an alkaline earth metal complex, a rare earth metal complex, or any combination thereof.

8 . The organic light-emitting device of claim 1 , wherein:

the emission layer comprises a first emission layer configured to emit a first color light,

the organic light-emitting device further comprises, between the first electrode and the second electrode, i) at least one second emission layer configured to emit a second color light or ii) the at least one second emission layer configured to emit the second color light and at least one third emission layer configured to emit a third color light,

a maximum emission wavelength of the first color light, a maximum emission wavelength of the second color light, and a maximum emission wavelength of the third color light are identical to or different from each other, and

the first color light and the second color light are emitted in a form of mixed light, or the first color light, the second color light, and the third color light are emitted in a form of mixed light.

9 . A heterocyclic compound represented by Formula 1:

wherein, in Formulae 1, 2-1 and 2-3,

X 1 to X 3 are each independently N or C(R 15 ), wherein at least one selected from X 1 to X 3 is N,

L 1 to L 3 are each independently a substituted or unsubstituted C 3 -C 60 carbocyclic group or a substituted or unsubstituted C 1 -C 60 heterocyclic group,

a1 to a3 are each independently an integer from 0 to 3,

Ar 1 is a group represented by Formula 2-1, Ar 2 is a group represented by Formula 2-3, and Ar 3 is group represented by Formula 2-3,

R 1 is selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 2 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —S(═O) 2 (Q 1 ), and —P(═O)(Q 1 )(Q 2 ),

R 4 and R 5 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, an unsubstituted C 2 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 1 )(Q 2 )(Q 3 ), —N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —S(═O) 2 (Q 1 ), and —P(═O)(Q 1 )(Q 2 ),

b4 is an integer from 1 to 4, and b5 is an integer from 1 to 5,

at least one selected from the R 1 of Formula 2-1 is —Si(Q 1 )(Q 2 )(Q 3 ),

at least one substituent of the substituted C 3 -C 60 carbocyclic group, the substituted C 1 -C 60 heterocyclic group, the substituted C 1 -C 60 alkyl group, the substituted C 2 -C 60 alkenyl group, the substituted C 2 -C 60 alkynyl group, the substituted C 1 -C 60 alkoxy group, the substituted C 3 -C 10 cycloalkyl group, the substituted C 2 -C 10 heterocycloalkyl group, the substituted C 3 -C 10 cycloalkenyl group, the substituted C 2 -C 10 heterocycloalkenyl group, the substituted C 6 -C 60 aryl group, the substituted C 6 -C 60 aryloxy group, the substituted C 6 -C 60 arylthio group, the substituted C 2 -C 60 heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group is selected from:

deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, and a C 1 -C 60 alkoxy group;

a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, and a C 1 -C 60 alkoxy group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —Si(Q 11 )(Q 12 )(Q 13 ), —N(Q 11 )(Q 12 ), —B(Q 11 )(Q 12 ), —C(═O)(Q 11 ), —S(═O) 2 (Q 11 ), and —P(═O)(Q 11 )(Q 12 );

a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group;

a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryloxy group, a C 6 -C 60 arylthio group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, a terphenyl group, —Si(Q 21 )(Q 22 )(Q 23 ), —N(Q 21 )(Q 22 ), —B(Q 21 )(Q 22 ), —C(═O)(Q 21 ), —S(═O) 2 (Q 21 ), and —P(═O)(Q 21 )(Q 22 ); and

—Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), —B(Q 31 )(Q 32 ), —C(═O)(Q 31 ), —S(═O) 2 (Q 31 ), and —P(═O)(Q 31 )(Q 32 ),

Q 1 to Q 3 , Q 11 to Q 13 , Q 21 to Q 23 , and Q 31 to Q 33 are each independently selected from:

hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryl group substituted with a C 1 -C 60 alkyl group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group; and

a C 1 -C 60 alkyl group, a C 2 -C 60 alkenyl group, a C 2 -C 60 alkynyl group, a C 1 -C 60 alkoxy group, a C 3 -C 10 cycloalkyl group, a C 1 -C 10 heterocycloalkyl group, a C 3 -C 10 cycloalkenyl group, a C 1 -C 10 heterocycloalkenyl group, a C 6 -C 60 aryl group, a C 6 -C 60 aryl group substituted with a C 1 -C 60 alkyl group, a C 1 -C 60 heteroaryl group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, a biphenyl group, and a terphenyl group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amidino group, a hydrazino group, a hydrazono group, a C 1 -C 60 alkyl group, and —Si(R a )(R b )(R c ),

R a to R c are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, a substituted or unsubstituted C 2 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group,

* indicates a binding site to a neighboring atom.

10 . The heterocyclic compound of claim 9 , wherein:

L 1 to L 3 are each independently selected from:

a benzene group, a pentalene group, an indene group, a naphthalene group, an azulene group, a heptalene group, an indacene group, an acenaphthalene group, a fluorene group, a spiro-bifluorene group, a spiro-benzofluorene-fluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pyrrole group, a thiophene group, a furan group, a silole group, an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, a triazine group, a benzofuran group, a benzothiophene group, a benzosilole group, a dibenzosilole group, a quinoline group, an isoquinoline group, a benzimidazole group, an imidazopyridine group, and an imidazopyrimidine group;

a benzene group, a pentalene group, an indene group, a naphthalene group, an azulene group, a heptalene group, an indacene group, an acenaphthalene group, a fluorene group, a spiro-bifluorene group, a spiro-benzofluorene-fluorene group, a benzofluorene group, a dibenzofluorene group, a phenalene group, a phenanthrene group, an anthracene group, a fluoranthene group, a pyrene group, a chrysene group, a naphthacene group, a picene group, a perylene group, a pyrrole group, a thiophene group, a furan group, a silole group, an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a pyridine group, a pyrazine group, a pyrimidine group, a pyridazine group, a triazine group, a benzofuran group, a benzothiophene group, a benzosilole group, a dibenzosilole group, a quinoline group, an isoquinoline group, a benzimidazole group, an imidazopyridine group, and an imidazopyrimidine group, each substituted with at least one selected from deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a pentalenyl group, an indenyl group, a naphthyl group, an azulenyl group, a heptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a pyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group, a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenyl group, a coronenyl group, an ovalenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group, a benzofuranyl group, a benzothiophenyl group, —Si(Q 31 )(Q 32 )(Q 33 ), —N(Q 31 )(Q 32 ), and —B(Q 31 )(Q 32 ), and

Q 31 to Q 33 are each independently selected from a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, and a pyridinyl group.

11 . The heterocyclic compound of claim 9 , wherein:

L 1 to L 3 are each independently selected from groups represented by Formulae 3-1 to 3-27:

wherein, in Formulae 3-1 to 3-27,

Y 11 is selected from C(Z 3 )(Z 4 ), N(Z 5 ), Si(Z 6 )(Z 7 ), O, and S,

Z 1 to Z 7 are each independently selected from hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, a silolyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a benzofuranyl group, a benzothiophenyl group, a benzosilolyl group, a dibenzosilolyl group, and —Si(Q 31 )(Q 32 )(Q 33 ),

Q 31 to Q 33 are each independently selected from a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, and a pyridinyl group,

d2 is an integer from 0 to 2,

d3 is an integer from 0 to 3,

d4 is an integer from 0 to 4,

d6 is an integer from 0 to 6,

d8 is an integer from 0 to 8, and

* and *′ each indicate a binding site to a neighboring atom.

12 . The heterocyclic compound of claim 9 , wherein:

Ar 1 is a group represented by one selected from Formulae 2-1(1) to 2-1(3), Ar 2 is a group represented by one selected from Formulae 2-3(1) and 2-3(2), and Ar 2 is a group represented by one selected from Formulae 2-3(1) and 2-3(2):

wherein, in Formulae 2-1(1) to 2-1(3), and 2-3(1) and 2-3(2),

Z 11 to Z 15 are each independently selected from hydrogen, deuterium, —F, —CI, —Br, —I, a hydroxyl group, a cyano group, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, a fluorenyl group, a spiro-bifluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, a silolyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a benzofuranyl group, a benzothiophenyl group, a benzosilolyl group, a dibenzosilolyl group, and —Si(Q 31 )(Q 32 )(Q 33 ),

wherein, in Formulae 2-3(1) and 2-3(2) at least one selected from Z 11 and Z 12 is present and selected from deuterium, —F, —CI, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 alkyl group, a substituted or unsubstituted C 2 -C 60 alkenyl group, a substituted or unsubstituted C 2 -C 60 alkynyl group, a substituted or unsubstituted C 1 -C 60 alkoxy group, a substituted or unsubstituted C 3 -C 10 cycloalkyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkyl group, a substituted or unsubstituted C 3 -C 10 cycloalkenyl group, a substituted or unsubstituted C 2 -C 10 heterocycloalkenyl group, a substituted or unsubstituted C 6 -C 60 aryl group, a substituted or unsubstituted C 6 -C 60 aryloxy group, a substituted or unsubstituted C 6 -C 60 arylthio group, an unsubstituted C 2 -C 60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group,—N(Q 1 )(Q 2 ), —B(Q 1 )(Q 2 ), —S(═O)2(Q 1 ), and —P(═O)(Q 1 )(Q 2 ),

Q 31 to Q 33 are each independently selected from a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a phenyl group, a biphenyl group, a terphenyl group, a naphthyl group, and a pyridinyl group,

e4 is an integer from 0 to 4,

e5 is an integer from 0 to 5,

Ph indicates a phenyl group, and

* indicates a binding site to a neighboring atom.

13 . The heterocyclic compound of claim 12 , wherein:

Ar 1 is a group represented by one selected from Formulae 2-1(2), and 2-1(3), Ar 2 is a group represented by one selected from Formulae 2-3(2), and Ar 3 is a group represented by one selected from Formulae 2-3(2).

14 . The heterocyclic compound of claim 9 , wherein:

Ar 1 is a group represented by one selected from Formulae 4-3 and 4-4, Ar 2 is a group represented by one selected from Formulae 4-12, 4-13, and 4-15, and Ar 3 is a group represented by one selected from Formulae 4-12, 4-13, and 4-15:

wherein, in Formulae 4-3, 4-4, 4-12, 4-13, and 4-15,

Ph indicates a phenyl group, and t-Bu indicates a tert-butyl group, and

* indicates a binding site to a neighboring atom.

15 . The heterocyclic compound of claim 9 , wherein:

i) X 1 to X 3 are each N;

ii) X 1 and X 2 are each N, and X 3 is C(R 15 );

iii) X 1 and X 3 are each N, and X 2 is C(R 15 );

iv) X 2 and X 3 are each N, and X 1 is C(R 15 );

v) X 1 is N, and X 2 and X 3 are each C(R 15 );

vi) X 2 is N, and X 1 and X 3 are each C(R 15 ); or vii) X 3 is N, and X 1 and X 2 are each C(R 15 ), and R 15 is hydrogen.

16 . The heterocyclic compound of claim 9 , wherein:

the heterocyclic compound is selected from Compounds 4, 5, 6, 17, 32 to 34, and 59:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2019
From: AHN, HEECHOON; KIM, HYEONGMIN; UM, HYUNAH; LEE, YESEUL; IM, YIRANG; KO, SOOBYUNG; KIM, YOUNGKOOK
To: SAMSUNG DISPLAY CO., LTD.
Reel/Frame 049934/0906 →
Priority Claims (1)
KR 10-2018-0147692 · Nov 26, 2018 · national
Continuity (1)
Related Publication 20200168819A1 · May 28, 2020
References Cited (147)
US 6310360B1 · Forrest et al. · 2001 [cited by applicant]
US 6515298B2 · Forrest et al. · 2003 [cited by applicant]
US 7279704B2 · Walters et al. · 2007 [cited by applicant]
US 7381479B2 · Lamansky et al. · 2008 [cited by applicant]
US 7393599B2 · Thompson et al. · 2008 [cited by applicant]
US 7585573B2 · Lee et al. · 2009 [cited by applicant]
US 7776458B2 · Ragini et al. · 2010 [cited by applicant]
US 7990046B2 · Iwakuma et al. · 2011 [cited by applicant]
US 8106199B2 · Jabbour et al. · 2012 [cited by applicant]
US 8389725B2 · Li et al. · 2013 [cited by applicant]
US 8669364B2 · Li et al. · 2014 [cited by applicant]
US 8680760B2 · Cheng et al. · 2014 [cited by applicant]
US 8816080B2 · Li et al. · 2014 [cited by applicant]
US 8846940B2 · Li et al. · 2014 [cited by applicant]
US 8946417B2 · Jian et al. · 2015 [cited by applicant]
US 9051344B2 · Lin et al. · 2015 [cited by applicant]
US 9076974B2 · Li et al. · 2015 [cited by applicant]
US 9082986B2 · Kato et al. · 2015 [cited by applicant]
US 9203039B2 · Li et al. · 2015 [cited by applicant]
US 9221857B2 · Li et al. · 2015 [cited by applicant]
US 9224963B2 · Li et al. · 2015 [cited by applicant]
US 9238668B2 · Li et al. · 2016 [cited by applicant]
US 9312502B2 · Li et al. · 2016 [cited by applicant]
US 9324957B2 · Li et al. · 2016 [cited by applicant]
US 9382273B2 · Li et al. · 2016 [cited by applicant]
US 9425415B2 · Li et al. · 2016 [cited by applicant]
US 9458182B2 · Langer et al. · 2016 [cited by applicant]
US 9548467B2 · Archer · 2017 [cited by applicant]
US 9786858B2 · Adamovich et al. · 2017 [cited by applicant]
US 9991454B2 · Kim et al. · 2018 [cited by applicant]
US 10177329B2 · Kim et al. · 2019 [cited by applicant]
US 10411211B2 · Tsukamoto et al. · 2019 [cited by applicant]
US 10483328B2 · Lee et al. · 2019 [cited by applicant]
US 10559758B2 · Park et al. · 2020 [cited by applicant]
US 20010008271A1 · Ikeda et al. · 2001 [cited by applicant]
US 20050287394A1 · Yang et al. · 2005 [cited by applicant]
US 20050287396A1 · Nakamura et al. · 2005 [cited by applicant]
US 20060103298A1 · Lee · 2006 [cited by applicant]
US 20080018221A1 · Egen et al. · 2008 [cited by applicant]
US 20090295274A1 · Hwang et al. · 2009 [cited by applicant]
US 20100127616A1 · Kai et al. · 2010 [cited by applicant]
US 20100219397A1 · Watanabe et al. · 2010 [cited by applicant]
US 20100270916A1 · Xia et al. · 2010 [cited by applicant]
US 20110301351A1 · Li et al. · 2011 [cited by applicant]
US 20120228583A1 · Wu et al. · 2012 [cited by applicant]
US 20130105777A1 · Adamovich et al. · 2013 [cited by applicant]
US 20130200357A1 · Ludemann et al. · 2013 [cited by applicant]
US 20140309428A1 · Egen et al. · 2014 [cited by applicant]
US 20150041770A1 · Lee · 2015 [cited by applicant]
US 20150105556A1 · Li et al. · 2015 [cited by applicant]
US 20150137051A1 · Jung et al. · 2015 [cited by applicant]
US 20150137095A1 · Xia et al. · 2015 [cited by applicant]
US 20150318487A1 · Ito et al. · 2015 [cited by applicant]
US 20160028025A1 · Ogiwara et al. · 2016 [cited by applicant]
US 20160240799A1 · Tsai et al. · 2016 [cited by applicant]
US 20160372687A1 · Murer et al. · 2016 [cited by applicant]
US 20170018600A1 · Ito et al. · 2017 [cited by applicant]
US 20170062730A1 · Ahn et al. · 2017 [cited by applicant]
US 20170077420A1 · Li et al. · 2017 [cited by applicant]
US 20170125699A1 · Ahn et al. · 2017 [cited by applicant]
US 20170149008A9 · Forrest et al. · 2017 [cited by applicant]
US 20170207398A1 · Yang · 2017 [cited by examiner]
US 20170309841A1 · Kim et al. · 2017 [cited by applicant]
US 20180051003A1 · Koo · 2018 [cited by examiner]
US 20180261791A1 · Yoo et al. · 2018 [cited by applicant]
US 20190109287A1 · Wu et al. · 2019 [cited by applicant]
US 20200258009A1 · Colon · 2020 [cited by examiner]
US 20200328359A1 · Ko · 2020 [cited by examiner]
US 20210098714A1 · Choi · 2021 [cited by examiner]
US 20210098716A1 · Lee · 2021 [cited by examiner]
US 20210098721A1 · Jung · 2021 [cited by examiner]
US 20210384450A1 · Shin · 2021 [cited by examiner]
US 20220013737A1 · Kang et al. · 2022 [cited by applicant]
US 20220024958A1 · Ko · 2022 [cited by examiner]
US 20220052276A1 · Lee · 2022 [cited by examiner]
US 20220069235A1 · Kim · 2022 [cited by examiner]
US 20230279029A1 · Fleetham · 2023 [cited by examiner]
CN 1402885A · 2003 [cited by applicant]
CN 101253185A · 2008 [cited by applicant]
CN 103563118A · 2014 [cited by applicant]
CN 104370974A · 2015 [cited by applicant]
CN 104411702A · 2015 [cited by applicant]
CN 106232770A · 2016 [cited by applicant]
CN 106795166A · 2017 [cited by applicant]
CN 107431084A · 2017 [cited by applicant]
CN 1129123040A · 2021 [cited by applicant]
JP 2004234952A · 2004 [cited by applicant]
JP 200745742A · 2007 [cited by applicant]
JP 2011140475A · 2011 [cited by applicant]
JP 015185728A · 2015 [cited by applicant]
JP 2017120867A · 2017 [cited by applicant]
JP 6232052B2 · 2017 [cited by applicant]
KR 100730115B1 · 2007 [cited by applicant]
KR 1020070106082A · 2007 [cited by applicant]
KR 1020080037006A · 2008 [cited by applicant]
KR 1020100118700A · 2010 [cited by applicant]
KR 1020120021215A · 2012 [cited by applicant]
KR 102013004870A · 2013 [cited by applicant]
KR 1020130115027A · 2013 [cited by applicant]
KR 1020130118084A · 2013 [cited by applicant]
KR 1020140041732A · 2014 [cited by applicant]
KR 1020140134947A · 2014 [cited by applicant]
KR 101502316 · 2015 [cited by applicant]
KR 101505152B1 · 2015 [cited by applicant]
KR 1020150114791A · 2015 [cited by applicant]
KR 1020160045604 · 2016 [cited by applicant]
KR 1020160060569 · 2016 [cited by applicant]
KR 1020160073482 · 2016 [cited by applicant]
KR 1020160110764A · 2016 [cited by applicant]
KR 1020170008358 · 2017 [cited by applicant]
KR 1020170008673A · 2017 [cited by applicant]
KR 1020170103358A · 2017 [cited by applicant]
KR 1020180104258A · 2018 [cited by applicant]
KR 1020180115800A · 2018 [cited by applicant]
WO 0108230A1 · 2001 [cited by applicant]
WO WO2008096609A1 · 2008 [cited by applicant]
WO WO2010126234A1 · 2010 [cited by applicant]
WO WO2012121936A2 · 2012 [cited by applicant]
WO 2014003440A1 · 2014 [cited by applicant]
WO WO2015000955A1 · 2015 [cited by applicant]
WO 2016080749A1 · 2016 [cited by applicant]
WO WO2016080791A1 · 2016 [cited by applicant]
WO WO2017082169A1 · 2017 [cited by applicant]
WO 2020096167A1 · 2020 [cited by applicant]
CAS reg. No. 2422045-58-5. Jun. 10, 2020. (Year: 2020). [cited by examiner]
EPO Extended European Search Report dated Jun. 11, 2021, issued in corresponding European Patent Application No. 21159426.2 (8 pages). [cited by applicant]
EPO Partial European Search Report dated Jul. 21, 2021, issued in corresponding European Patent Application No. 21159425.4 (18 pages). [cited by applicant]
Esteruelas, Miguel A., et al., “Preparation of Phosphorescent Iridium(III) Complexes with a Dianionic C,C,C,C-Tetradentate Ligand,” Inorg. Chem. 2018, 57, 7, pp. 3720-3730. [cited by applicant]
Office Action for U.S. Appl. No. 16/666,327 dated Jun. 6, 2022, 24 pages. [cited by applicant]
Pang et al. “A Full-Color, Low-Power, Wearable Display for Mobile Applications,” SPIE, Mar. 29, 2012, 5 pages. [cited by applicant]
English Translation of International Preliminary Report issued in PCT/KR2019/009197, Search Authority search carriec JUI dated Feb. 22, 2021, 3 pages. [cited by applicant]
Intemational Search Report issued in PCT/KR2019/009197 (English Version), dated Oct. 21, 2019, 2 pages. [cited by applicant]
U.S. Final Office Action dated Nov. 16, 2022, issued in U.S. Appl. No. 16/666,327 (33 pages). [cited by applicant]
U.S. Advisory Action dated Jan. 25, 2023, issued in U.S. Appl. No. 16/666,327 (3 pages). [cited by applicant]
U.S. Office Action dated Mar. 14, 2023, issued in U.S. Appl. No. 16/666,327 (41 pages). [cited by applicant]
U.S. Final Office Action dated Sep. 13, 2023, issued in U.S. Appl. No. 16/666,327 (24 pages). [cited by applicant]
“Analog Electronic Technology”, with English Abstract, dated Jul. 31, 2010, 22 pages. [cited by applicant]
Chinese Office Action for Chinese Patent Application No. 202010073332.8, dated Mar. 18, 2024, 29 pages. [cited by applicant]
US Office Action dated Apr. 18, 2024, issued in U.S. Appl. No. 16/666,327 (24 pages). [cited by applicant]
Chinese Office Action dated Jan. 27, 2024 issued in Chinese Patet Application No. 201980068141.8, 11 pages. [cited by applicant]
Huei-Ru Tsai et al. “Metal-Ligand Bonding Strength of Fluoro-Substituted Cyclometalated Iridium(III) Complexes from Raman and Infrared Spectra”, J. Phys. Chem. 2011, vol. 115, p. 17163-17174 (Year: 2011). [cited by applicant]
US Final Office Action dated Sep. 6, 2024, issued in U.S. Appl. No. 16/666,327 (29 pages). [cited by applicant]
US Office Action dated Feb. 13, 2025, issued in U.S. Appl. No. 16/666,327 (42 pages). [cited by applicant]
US Office Action dated Jul. 2, 2025, issued in U.S. Appl. No. 16/666,327 (26 pages). [cited by applicant]
US Office Action dated Aug. 1, 2025, issued in U.S. Appl. No. 17/660,182 (11 pages). [cited by applicant]
US Notice of Allowance dated Sep. 23, 2025, issued in U.S. Appl. No. 16/666,327 (10 pages). [cited by applicant]
US Final Office Action dated Dec. 9, 2025, issued in U.S. Appl. No. 17/660,182 (10 pages). [cited by applicant]